【clay maxey ford in berryville arkansas】Why Tesla, MyoKardia, and Hologic Slumped Today
Wednesday was a positive day on Wall Street,clay maxey ford in berryville arkansas though investors remained uncertain about the prospects for the stock market in 2019. Volatility was back, but key indexes managed to recover their losses from early in the session. Between the ongoing government shutdown and continuing worries about global macroeconomic and geopolitical factors, however, investors found it hard to build much positive momentum, and the major benchmarks only made small gains. As for individual stocks, Tesla (NASDAQ: TSLA) , MyoKardia (NASDAQ: MYOK) , and Hologic (NASDAQ: HOLX) were among the worst performers. Here's why they did so poorly. Tesla cuts prices as production slumps Shares of Tesla fell 7% as investors reacted negatively to a pair of news items about the electric-car company. First, Tesla said that it would reduce prices on all of its car models by $2,000 per vehicle in the U.S. market, raising concerns about whether demand for Tesla cars is holding up well. Moreover, Tesla's latest numbers on delivery volume were weaker than expected, with an overall 8% rise over the past three months to 90,700 vehicles falling short of consensus projections by about 1,300. With tax credits shrinking, Tesla's having to generate more of its customer demand without the help of subsidies, and that could prove difficult going forward. Blue Model 3 on a road in front of a landscape of grassy hills and hazy skies. Image source: Tesla. MyoKardia's collaboration with Sanofi to end MyoKardia's stock dropped 14% after the clinical-stage biopharmaceutical company announced that its collaboration agreement with Sanofi won't be extended after having expired at the end of 2018. The move returns global rights to candidate cardiovascular treatments mavacamten and MYK-491 to MyoKardia, leaving it up to the company to move forward with the lead candidates. Investors have been excited about MyoKardia's potential for a long time , but it's hard not to take Sanofi's decision as a vote of no confidence about the company's treatments. Hologic deals with a downgrade Finally, shares of Hologic finished lower by 6.5%. The medical technology company received negative comments from stock analysts at Morgan Stanley, who downgraded Hologic from equal weight to underweight. Despite initially favorable expectations for Hologic's aesthetic surgical division , analysts believe that strong competition and potential regulatory scrutiny in some areas could cause the company to fall short of hopes. With a $5-per-share reduction in the analyst's target price on the stock to $39, Hologic will need to see business pick up in order to prove the Wall Street giant wrong. Story continues More From The Motley Fool 10 Best Stocks to Buy Today 3 Stocks That Are Absurdly Cheap Right Now 5 Warren Buffett Principles to Remember in a Volatile Stock Market The $16,728 Social Security Bonus You Cannot Afford to Miss The Must-Read Trump Quote on Social Security 10 Reasons Why I'm Selling All of My Apple Stock Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Tesla. The Motley Fool has a disclosure policy . View comments
相关推荐
-
EUR/USD Bullish Break Kick Starts Reversal to 1.13?
-
Energy Fuels Inc.'s (TSE:EFR) Intrinsic Value Is Potentially 96% Above Its Share Price
-
Halozyme Therapeutics, Inc. Just Recorded A 24% EPS Beat: Here's What Analysts Are Forecasting Next
-
Gamesys Group PLC Announces Total Voting Rights
-
Where Do Hedge Funds Stand On Pacific Mercantile Bancorp (PMBC)?
-
Are Robust Financials Driving The Recent Rally In Arthur J. Gallagher & Co.'s (NYSE:AJG) Stock?
- 最近发表
-
- IIOT-OXYS, Provides Business Update on COVID-19
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Evolus, Inc. of Class Action Lawsuit and Upcoming Deadline – EOLS
- Ex-Tesla employee agrees to pay $400K over claims he stole trade secrets
- Asian Shares Lower as US-China Tensions Weigh on Investor Sentiment
- This Broker Just Slashed Their Freelance.com SA (EPA:ALFRE) Earnings Forecasts
- Lockheed Martin (LMT) Wins $1B Deal for Super Hercules Fleet
- Were Hedge Funds Right About Advanced Micro Devices, Inc. (AMD)?
- DCP Midstream to Participate in Investor Conferences
- Calculating The Intrinsic Value Of FFI Holdings Limited (ASX:FFI)
- It's not over until there is no virus anywhere in the world - WHO
- 随机阅读
-
- Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
- IMPORTANT APRIL DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MGP Ingredients, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- Buy Ferrari Stock After Scuderia-Velas NFT deal?
- Best Tarot Cards Reading Online By Kasamba Tarot Readers Experts - How To get Free Love Tarot Readings Online
- How Does Duluth Holdings's (NASDAQ:DLTH) P/E Compare To Its Industry, After The Share Price Drop?
- H2O Innovation Secures 7 New Projects, Totalling $7.6 M and Received Notice of Cancellation for One Project
- Lam Research (LRCX) Stock Moves -1.58%: What You Should Know
- LeadsRx and WideOrbit Partnership Gives Advertisers Access to Advertising Campaign Data to Maximize ROAS
- Toll Brothers Makes Wedbush's Best Ideas List: Here's Why
- Ra Medical Systems, Inc. to Host Earnings Call
- Hedge Funds Aren’t Done Buying Tech Data Corp (TECD)
- Arch Coal (ARCH) Down 22.8% Since Last Earnings Report: Can It Rebound?
- Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
- Cargotec completes the ownership change of joint venture in China
- Companies slammed by coronavirus look to cut contributions to their employees' 401(k)s
- Russia's Ozon wants dual listing in Moscow and U.S. -sources
- What Kind Of Shareholders Hold The Majority In Select Bancorp, Inc.'s (NASDAQ:SLCT) Shares?
- Avista (AVA) Misses Q3 Earnings and Revenue Estimates
- Expanse Integrates with ServiceNow
- Hedge Funds Souring On E*TRADE Financial (ETFC)
- 搜索
-
- 友情链接
-
- Facebook isn't sorry about its shady 'research' app
- Democrats want government to have power over the patient: Sen. Bill Cassidy
- The hot new item from 1-800-Flowers.com isn’t flowers
- 4 Potential Drawbacks of 529 Plans and How to Minimize Them
- A Look At The Fair Value Of Watkin Jones Plc (LON:WJG)
- For France's Macron, 2020 again brings rocky start, outlook
- Do Directors Own LiveXLive Media, Inc. (NASDAQ:LIVX) Shares?
- Communiqué: Orange acquires SecureData to increase its international reach and expertise in cybersecurity
- Why Prana Biotechnology Stock Is Skyrocketing Today
- Maynard James Keenan on “Arrogant” Pandemic Behavior: “There’s Logic Attached to Just Looking Out for Each Other”